Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study)
This study is currently recruiting participants.
Study NCT00377468   Information provided by Ludwig-Maximilians - University of Munich
First Received: September 14, 2006   Last Updated: June 26, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Complex Regional Pain Syndromes
CRPS
Additional conditions recognized in this trial
Somatoform Disorders
Syndrome
More general conditions related to this trial
Autonomic Nervous System Diseases
Disease
Mental Disorders
Nervous System Diseases
Neuromuscular Diseases
Pathologic Processes
Peripheral Nervous System Diseases
Interventions listed in this trial
Delta9-Tetrahydrocannabinol
Additional drug interventions recognized in this trial
Tetrahydrocannabinol
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Central Nervous System Agents
Hallucinogens
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Ludwig-Maximilians - University of Munich
German Federal Ministry of Education and Research
German Research Network on Neuropathic Pain


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services